2018
Depression and Alzheimer’s Disease Biomarkers Predict Driving Decline
Click here to read the article
Babulal, G. M., Chen, S., Williams, M. M., Trani, J. F., Bakhshi, P., Chao, G. L., Stout, S. H., Fagan, A. M., Benzinger, T., Holtzman, D. M., Morris, J. C., & Roe, C. M. (2018). Depression and Alzheimer’s Disease Biomarkers Predict Driving Decline. Journal of Alzheimer’s Disease: JAD, 66(3), 1213–1221.
Incident Cognitive Impairment: Longitudinal Changes in Molecular, Structural and Cognitive Biomarkers
Click here to read the article
Roe, C. M., Ances, B. M., Head, D., Babulal, G. M., Stout, S. H., Grant, E. A., Hassenstab, J., Xiong, C., Holtzman, D. M., Benzinger, T., Schindler, S. E., Fagan, A. M., & Morris, J. C. (2018). Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain, 141(11), 3233–3248.
Using the A/T/N Framework to Examine Driving in Preclinical AD
Click here to read the article
Roe, C. M., Babulal, G. M., Stout, S. H., Ott, B. R., Carr, D. B., Williams, M. M., Benzinger, T., Fagan, A. M., Holtzman, D. M., Ances, B. M., & Morris, J. C. (2018). Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics, 3(2), 23.
Driving Outcomes among Older Adults: A Systematic Review on Racial and Ethnic Differences over 20 Years
Click here to read the article
Babulal, G. M., Williams, M. M., Stout, S. H., & Roe, C. M. (2018). Driving Outcomes among Older Adults: A Systematic Review on Racial and Ethnic Differences over 20 Years. Geriatrics. 3(1), 12.
Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities
Click here to read the article
Driving Cessation Over a 24 Year Period: Dementia Severity and CSF Biomarkers
Click here to read the article
Stout, S. H., Babulal, G. M., Ma, C., Carr, D. B., Head, D. M., Grant, E. A., Williams, M. M., Holtzman, D. M., Fagan, A. M., Morris, J. C., & Roe, C. M. (2018). Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14(5), 610–616.
Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies
2017
Differentiating Cognitive Impairment Due to Corticobasal Degeneration and Alzheimer Disease
Click here to read the article
Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers Predict Driving Decline: Brief Report
Click here to read the article
2016
Brain Amyloid in Preclinical Alzheimer’s Disease is Associated with Increased Driving Risk
Click here to read the article
Ott B. R., Jones, R. N., Noto, R. B., Yoo D. C., Snyder, P. J., Bernier J. N., Carr, D. B., Roe, C. M. (2016). Brain amyloid in preclinical Alzheimer’s disease is associated with increased driving risk. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 6(1), 136-142.
Creating a Driving Profile for Older Adults Using GPS Devices and Naturalistic Driving Methodology
Click here to read the article
Babulal G. M., Traub, C. M., Webb, M., Stout, S. H., Addison, A., Carr, D. B., Ott, B. R., Morris, J. C., Roe, C. M. (2016). Creating a driving profile for older adults using GPS devices and naturalistic driving methodology [version 2; referees: 3 approved]. F1000Research, 5, 2376.
Association of Functional Impairments and Co-morbid Conditions with Driving Performance Among Cognitively Normal Older Adults
Click here to read the article
Carr, D. B., Barco, P. P., Babulal, G. M., Stout, S. H., Johnson, A. M., Xiong, C., Morris, J. C., & Roe, C. M. (2016). Association of functional impairments and co-morbid conditions with driving performance among cognitively normal older adults. PLOS ONE, 11(12).
Development and Interval Testing of a Naturalistic Driving Methodology to Evaluate Driving Behavior in Clinical Research
Click here to read the article
Babulal, G. M., Addison, A., Ghoshal, N., Stout, S. H., Vernon, E. K., Sellan, M., & Roe, C. M. (2016). Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research. F1000Research, 5, 1716.
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer’s Disease Biomarker Levels
Click here to read the article
Babulal, G. M., Ghoshal, N., Head, D., Vernon, E. K., Holtzman, D. M., Benzinger, T., Fagan, A. M., Morris, J. C., & Roe, C. M. (2016). Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. The American journal of Geriatric Psychiatry, 24(11), 1095–1104.
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals
Click here to read the article
Roe, C. M., Barco, P. P., Head, D. M., Ghoshal, N., Selsor, N., Babulal, G. M., Fierberg, R., Vernon, E. K., Shulman, N., Johnson, A., Fague, S., Xiong, C., Grant, E. A., Campbell, A., Ott, B. R., Holtzman, D. M., Benzinger, T. L., Fagan, A. M., Carr, D. B., & Morris, J. C. (2017). Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Disease and Associated Disorders, 31(1), 69–72.
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future “Non-Cognitive” Outcomes of Alzheimer’s Disease
Click here to read the article
Ingber, A. P., Hassenstab, J., Fagan, A. M., Benzinger, T. L., Grant, E. A., Holtzman, D. M., Morris, J. C., & Roe, C. M. (2016). Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future “Non-Cognitive” Outcomes of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 52(3), 1055–1064.
2015
Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results
Click here to read the article
Gooblar, J., Roe, C. M., Selsor, N. J., Gabel, M. J., & Morris, J. C. (2015). Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results. JAMA Neurology, 72(12), 1484–1490.
Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology
Click here to read the article
Hassenstab, J., Monsell, S. E., Mock, C., Roe, C. M., Cairns, N. J., Morris, J. C., & Kukull, W. (2015). Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology. Journal of Neuropathology and Experimental Neurology, 74(11), 1086–1092.
“Noncognitive” Symptoms of Early Alzheimer Disease: A Longitudinal Analysis
Click here to read the article
Masters, M. C., Morris, J. C., & Roe, C. M. (2015). “Noncognitive” symptoms of early Alzheimer disease: a longitudinal analysis. Neurology, 84(6), 617–622.
The Effects of White Matter Hyperintensities and Amyloid Deposition on Alzheimer Dementia
Click here to read the article
Gordon, B. A., Najmi, S., Hsu, P., Roe, C. M., Morris, J. C., & Benzinger, T. L. (2015). The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia. NeuroImage. Clinical, 8, 246–252.
Pathological correlates of White Matter Hyperintensities on Magnetic Resonance Imaging
Click here to read the article
Shim, Y. S., Yang, D. W., Roe, C. M., Coats, M. A., Benzinger, T. L., Xiong, C., Galvin, J. E., Cairns, N. J., & Morris, J. C. (2015). Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dementia and geriatric cognitive disorders, 39(1-2), 92–104.
Clinical Features of Alzheimer Disease With and Without Lewy Bodies
Click here to read the article
Chung, E. J., Babulal, G. M., Monsell, S. E., Cairns, N. J., Roe, C. M., & Morris, J. C. (2015). Clinical Features of Alzheimer Disease With and Without Lewy Bodies. JAMA Neurology, 72(7), 789–796.
Adults Aged 65 and Older Use Potentially Distracting Electronic Devices While Driving
Click here to read the article
Vernon, E. K., Babulal, G. M., Head, D., Carr, D., Ghoshal, N., Barco, P. P., Morris, J. C., & Roe, C. M. (2015). Adults Aged 65 and Older Use Potentially Distracting Electronic Devices While Driving. Journal of the American Geriatrics Society, 63(6), 1251–1254.
Increased Susceptibility to Oxidative Death of Lymphocytes from Alzheimer Patients Correlates with Dementia Severity
Click here to read the article
Ponce, D. P., Salech, F., SanMartin, C. D., Silva, M., Xiong, C., Roe, C. M., Henriquez, M., Quest, A. F., & Behrens, M. I. (2014). Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity. Current Alzheimer Research, 11(9), 892–898.